ADENOCARCINOMA OF THE RECTUM
Clinical trials for ADENOCARCINOMA OF THE RECTUM explained in plain language.
Never miss a new study
Get alerted when new ADENOCARCINOMA OF THE RECTUM trials appear
Sign up with your email to follow new studies for ADENOCARCINOMA OF THE RECTUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo targets Hard-to-Treat colorectal cancer
Disease control Not yet recruitingThis trial investigates whether combining two drugs—trastuzumab deruxtecan (T-DXd) and cetuximab—can shrink tumors in people with advanced colorectal cancer that has low levels of the HER2 protein and has worsened after standard treatments. The study enrolls adults with metastati…
Matched conditions: ADENOCARCINOMA OF THE RECTUM
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Shorter radiation may be just as good for rectal cancer patients
Disease control Not yet recruitingThis study compares two standard radiotherapy approaches—short-course (1 week) and long-course (several weeks)—given before surgery to people with locally advanced rectal cancer. The goal is to see which one works better at shrinking tumors and is easier for patients to tolerate.…
Matched conditions: ADENOCARCINOMA OF THE RECTUM
Phase: NA • Sponsor: Rajiv Gandhi Cancer Institute & Research Center, India • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC